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Tamarindus indicaObjective: The objective of the present investigation was to evaluate the hypoglycemic potential of
Berberis aristata and Tamarindus indica using various in vitro techniques.
Methods: The selected plant extracts were studied for their effects on glucose adsorption capacity,
in vitro glucose diffusion, in vitro amylolysis kinetics and glucose transport across the yeast cells.
Results: It was observed that both the plant extracts adsorbed glucose and the adsorption of glucose
increased remarkably with an increase in glucose concentration. No significant (p 6 0.05) differences
were observed between the adsorption capacities of B. aristata and T. indica. The results of amylolysis
kinetic experimental model exhibited that the rate of glucose diffusion was increased with time from
30 to 180 min and both the plant extracts demonstrated significant inhibitory effects on movement of
glucose into external solution across dialysis membrane as compared to control. It was observed that
the plant extracts also promoted glucose uptake by the yeast cells. Enhancement of glucose uptake
was dependent on both the sample and glucose concentration. B. aristata extract exhibited significantly
higher (p 6 0.05) activity than the extract of T. indica at all concentrations.
Conclusion: The results of the study verified the hypoglycemic activity of the extracts of B. aristata and T.
indica. However, the observed effects need to be confirmed using different in vivo models and clinical tri-
als for their effective utilization as therapeutic agents.
 2016 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetesmellitus is a serious complex chronic condition that is a
major source of ill health worldwide [1]. It is characterized by
hyperglycemia and disturbances of carbohydrate, protein and fat
metabolisms, secondary to an absolute or relative lack of the hor-
mone insulin [1,2]. Presently the treatments of diabetes, in addition
to insulin supplement includes many oral hypoglycemic agents like
sulfonylureas, biguanides, thiazolidines, D-phenylalanine deriva-
tives, meglitinides and a-glucosidase inhibitors along with appro-
priate diet and exercise. However, none can be termed as an ideal
one, due to their toxic side effects and sometimes diminution in
response after prolonged use [3]. Plants play a major role in man-
agement of diabetes and have been used in traditional forms of
medicine [4]. Many herbal products including several metals and
minerals have been described for the care of diabetesmellitus. Plant
products are frequently considered to be less toxic and significantlyfree from side effects than synthetic ones [5]. Hence, the research is
more focused nowadays on herbal antidiabetic agents which may
prove to be beneficial and effective in the management of diabetes
and its complications.
Berberis aristata DC (Family: Berberidaceae) is used in Ayurveda
medicines from very long time. This plant has been considered as a
valuable medicine for the treatment of remittent fevers, oxidative
stress and used as a cooling laxative to children and as a tonic rem-
edy for liver and heart. Literature survey revealed that Berberis aris-
tata DC have been studied for febrifugal, hypotensive, immuno-
stimulating, anti-inflammatory, antidiabetic, antimicrobial,
antiprotozoal, anticholinergic, antiarrhythmic activities, antiplas-
modial activity hypolipidemic activity, anti-granuloma activity
and anti-hemolytic [6–10]. Tamarindus indica Linn. (Family: Legu-
minosae) is also one of the popular drugs in Ayurvedic system of
medicine. Its fruit is regarded as a digestive, carminative, laxative,
expectorant and blood tonic [11]. Other parts of the plant possess
antioxidant, antihepatotoxic, anti-inflammatory, antimutagenic,
antidiabetic activities and antihyperglycaemic activity [12–15].
The present study was undertaken to assess the hypoglycemic
potential of the roots of B. aristata and the seeds of T. indica usinglt Phar-
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action.
2. Materials and methods
2.1. Chemicals and reagents
Glucose oxidase peroxidase kit was purchased from Pathozyme
Diagnostics, Kagal, India. Dialysis bags (12,000 MW cutoff; Hime-
dia laboratories, India) were used in the study. All the chemicals
used in the study were of extra pure analytical grade.
2.2. Plant material
The plant material was collected from local areas of Kasegaon,
District Sangli, (MS), and was further identified and authenticated
by the Department of Botany, Science College, Karad. The roots of B.
aristata and the seeds of T. indica were cleaned, dried in a hot air
oven (50 C), powdered, passed through 60 mesh sieve (BS) and
stored in an airtight container at 4 C till further use.
2.3. Preparation of plant extracts
Aqueous extracts were prepared by extracting the powders of
roots of B. aristata and the seeds of T. indica with hot water
(70 C) in a mechanical shaker (24 h), filtered and freeze dried.
2.4. Evaluation of hypoglycemic activity of plant extracts using various
in vitro methods
2.4.1. Determination of glucose adsorption capacity
The samples of plant extracts (1%) were added to 25 ml of glu-
cose solution of increasing concentration (5, 10, 20, 50 and
100 mM). The mixture was stirred well, incubated in a shaker
water bath at 37 C for 6 h, centrifuged at 4,000g for 20 min and
the glucose content in the supernatant was determined. The con-
centration of bound glucose was calculated using the following for-
mula [16].
Glucose Bound ¼ G1  G6
Weight of the sample
 Volume of solution
G1 is the glucose concentration of original solution; G2 is the glu-
cose concentration after 6 h.
2.4.2. Effect of plant extracts on in vitro glucose diffusion
25 ml of glucose solution (20 mM) and the samples of plant
extracts (1%) were dialyzed in dialysis bags against 200 ml of dis-
tilled water at 37 C in a shaker water bath. The glucose content
in the dialysate was determined at 30, 60, 120 and 180 min using
glucose oxidase peroxidase diagnostic kit. A control test was car-
ried out without sample. Glucose dialysis retardation index (GDRI)
was calculated using the following formula [17].
GDRI ¼ 100 Glucose content with addition of sample ðmg=dlÞ
Glucose content of the control ðmg=dlÞ
 100Fig. 1. Glucose binding capacity of B. aristata and T .indica at different concentra-
tions of glucose. Values are mean ± SD of triplicate determinations.2.4.3. Effect of plant extracts on in vitro amylolysis kinetics
40 grams of potato starch was added to900 ml of 0.05 M phos-
phate buffer (pH 6.5). The solution after stirring at 65 C for 30 min
was made up to a final volume of 1000 ml to give a 4% (w/v) starch
solution. 25 ml of the above starch solution, a-amylase (0.4%), and
the plant extracts (1%) were dialyzed in a dialysis bags against
200 ml of distilled water at 37 C (pH 7.0) in a shaker water bath.Please cite this article in press as: M.A. Bhutkar et al., Hypoglycemic effects of B
macy Cairo Univ (2016), http://dx.doi.org/10.1016/j.bfopcu.2016.09.001The glucose content in the dialysate was determined at 30, 60,
120 and 180 min. A control test was carried out without sample
[16].
2.4.4. Glucose uptake by yeast cells
Commercial baker’s yeast was washed by repeated centrifuga-
tion (3000g; 5 min) in distilled water until the supernatant fluids
were clear and a 10% (v/v) suspension was prepared in distilled
water. Various concentrations of extracts (1–5 mg) were added to
1 ml of glucose solution (5–25 mM) and incubated together for
10 min at 37 C. The reaction was started by adding 100 ll of yeast
suspension, vortexed and further incubated at 37 C for 60 min.
After 60 min, the tubes were centrifuged (2500g, 5 min) and glu-
cose was estimated in the supernatant. The percent increase in glu-
cose uptake by yeast cells was calculated using the following
formula [18].
Increase in glucose uptake ð%Þ¼AbsorbancecontrolAbsorbancesample
Absorbancecontrol
100
where, Abs control is the absorbance of the control reaction (con-
taining all reagents except the test sample), and Abs sample is the
absorbance of the test sample.
2.5. Statistical analysis
All the determinations were carried out in triplicates and data
were analyzed by ANOVA followed by Tukey’s multiple compar-
isons test for significant differences. Values were considered at
p 6 0.05. Graphs were plotted using Graph Pad Prism 6 software.
3. Results and discussion
The results of glucose adsorption capacity of the selected plant
extracts are shown in Fig. 1. The adsorption capacities of the plant
extracts were found to be directly proportional to the molar con-
centration of glucose and higher amounts of glucose were bound
with an increased glucose concentration. No significant (p 6 0.05)
differences were observed between the adsorption capacities of
B. aristata and T. indica. The adsorption capacity of the extracts of
B. aristata and T. indica may be attributed to their phytocon-erberis aristata and Tamarindus indica extracts in vitro, Bulletin Facult Phar-
Table 1
Effect of selected samples on glucose diffusion and glucose dialysis retardation index.
Sample Glucose content in dialysate (mM)
30 min 60 min 120 min 180 min
Control 0.92c ± 0.01 1.32c ± 0.01 1.86c ± 0.01 1.98c ± 0.01
B. aristata 0.58a ± 0.01 (36.95) 1.02a ± 0.01 (22.72) 1.51a ± 0.01 (17.03) 1.70a ± 0.01 (14.14)
T. indica 0.64b ± 0.01 (30.43) 1.10b ± 0.01 (16.66) 1.67b ± 0.01 (10.21) 1.82b ± 0.01 (8.08)
Values in parenthesis indicate glucose dialysis retardation index (GDRI).
Mean values (n = 3) with different superscript letters in columns differ significantly from each other (p 6 0.05).
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Fig. 2. Effect of B. aristata extract on the uptake of glucose by yeast cells. Values are
mean ± SD of triplicate determinations.
Concentration (mg) of extract of T. indica
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Fig. 3. Effect of T. indica extract on the uptake of glucose by yeast cells. Values are
mean ± SD of triplicate determinations.
Table 2
Effect of selected samples on starch digestibility and glucose dialysis retardation index.
Sample Glucose content in dialysate (mM)
30 min 60 min 120 min 180 min
Control 0.0 0.23c ± 0.01 0.31c ± 0.01 0.40c ± 0.01
B. aristata 0.0 (100) 0.12a ± 0.01 (47.82) 0.24a ± 0.01 (22.58) 0.35a ± 0.01 (12.5)
T. indica 0.0 (100) 0.16b ± 0.01 (30.43) 0.27b ± 0.01 (12.90) 0.38b ± 0.01 (5.0)
Values in parenthesis indicate glucose dialysis retardation index (GDRI).
Mean values (n = 3) with different superscript letters in columns differ significantly from each other (p 6 0.05).
M.A. Bhutkar et al. / Bulletin of Faculty of Pharmacy, Cairo University xxx (2016) xxx–xxx 3stituents, as both insoluble and soluble constituents and fibers
from different sources are reported to adsorb glucose. The results
also indicated that the selected plant extracts could bind glucose
even at lower concentrations of glucose (5 mM) thereby decreasing
the amount of glucose available for transport across the intestinal
lumen, consequently blunting the postprandial hyperglycemia.
The effect of the selected plant extracts on retarding glucose dif-
fusion across the dialysis membrane is represented in Table 1. The
rate of glucose diffusion was found to increase with time from 30
to 180 min. During the study, the movement of glucose across the
dialysis membrane was monitored once in 30 min till 180 min and
it was observed that, both the samples of plant extracts demon-
strated significant inhibitory effects on movement of glucose into
external solution across dialysis membrane as compared to con-
trol. The retardation of glucose diffusion by B. aristata extract
was significantly higher (p 6 0.05) than T. indica. The effects were
reflected with a higher glucose dialysis retardation index (GDRI)
values for B. aristata than T. indica.
The effects of B. aristata and T. indica on the amylolysis kinetics
are highlighted in Table 2. Glucose dialysis retardation index
(GDRI) is an important in vitro index to predict the effect of a fiber
on the delay in glucose absorption in the gastrointestinal tract [19].
A higher GDRI indicates a higher retardation index of glucose by
the sample. The GDRI was found to be 47.82% and 30.43% for B.
aristata and T. indica respectively at 60 min which gradually got
reduced to 22.58% and 12.90% respectively at 120 min. The retar-
dation of glucose diffusion may also be due to the inhibition of
the enzyme, a-amylase by the plant extracts thereby reducing
the release of glucose from the starch.
The mechanism of glucose transport across the yeast cell mem-
brane has been receiving attention as in vitro screening method for
hypoglycemic effect of various compounds/medicinal plants [20–
23]. The results of the rate of glucose transport across cell mem-
brane in yeast cell system are represented in Figs. 2 and 3 for the
extracts of B. aristata and T. indica respectively. The amount of glu-
cose which remains in the medium after a specific time interval
serves as an indicator of the glucose uptake by the yeast cells.
The studies on the transport of nonmetabolizable sugars and cer-
tain metabolizable glycosides have suggested that sugar transport
across the yeast cell membrane is mediated by stereospecific
membrane carriers. It has also been reported that in yeast cells
(Saccharomyces cerevisiae) glucose transport is extremely complex
and it is generally agreed that glucose is transported in yeast cellsPlease cite this article in press as: M.A. Bhutkar et al., Hypoglycemic effects of Berberis aristata and Tamarindus indica extracts in vitro, Bulletin Facult Phar-
macy Cairo Univ (2016), http://dx.doi.org/10.1016/j.bfopcu.2016.09.001
4 M.A. Bhutkar et al. / Bulletin of Faculty of Pharmacy, Cairo University xxx (2016) xxx–xxxby a facilitated diffusion process. Facilitated carriers are specific
carriers that transport solutes down the concentration gradient.
It means that effective transport is only attained if there is removal
of intracellular glucose [17,18,20–23].
The rate of glucose uptake into the yeast cells was linear in all
the 5 glucose concentrations used in the study. The extract of B.
aristata exhibited significantly higher (p 6 0.05) activity than the
T. indica extract at all concentrations used in the study. The percent
increase in the glucose uptake by the yeast cells was found to be
inversely proportional to the glucose concentration and decreased
with an increase in the molar concentration of the glucose solution.4. Conclusion
The results of this study highlight the hypoglycemic properties
of B. aristata and T. indica as assessed by the various in vitro meth-
ods. The hypoglycemic activity of the extracts of B. aristata and T.
indica is mediated by increasing glucose adsorption, decreasing
glucose diffusion rate and at the cellular level by promoting glu-
cose transport across the cell membrane as revealed by simple
in vitro model of yeast cells. These effects need to be confirmed
by employing different in vivo models and clinical trials which
may contribute to their effective utilization as therapeutic agents.Conflict of interest
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